World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
29711
World Ranking
11775
National Ranking
6040

Carlos Rodriguez-Galindo publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Carlos Rodriguez-Galindo sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 624 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Carlos Rodriguez-Galindo D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Carlos Rodriguez-Galindo sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Carlos Rodriguez-Galindo is affiliated with St. Jude Children's Research Hospital in the United States. Their work is primarily located within the field of Medicine, with a significant focus on Pediatrics, Perinatology and Child Health, Oncology, Public Health, Environmental and Occupational Health, Radiology, Nuclear Medicine and Imaging, and General Health Professions.

The scientist's research topics encompass a range of areas related to childhood cancer and oncology. Key topics include:

  • Childhood Cancer Survivors' Quality of Life
  • Advances in Oncology and Radiotherapy
  • Palliative Care and End-of-Life Issues
  • Neuroblastoma Research and Treatments
  • COVID-19 and healthcare impacts
  • Acute Lymphoblastic Leukemia research
  • Glioma Diagnosis and Treatment

Carlos Rodriguez-Galindo has published extensively in several notable journals. Their frequent publication venues include:

  • Pediatric Blood & Cancer
  • JCO Global Oncology
  • Cancer
  • The Lancet Oncology
  • Journal of Clinical Oncology

Recent publications showcasing their research contributions include:

  • Langerhans cell histiocytosis, 2020, Blood
  • Sustainable care for children with cancer: a Lancet Oncology Commission, 2020, The Lancet Oncology
  • The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019, 2021, The Lancet Oncology
  • The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global, 2020, Pediatric Blood & Cancer
  • Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology, 2020, Journal of Clinical Oncology

The researcher collaborates frequently with several colleagues, including:

  • Daniel C. Moreira
  • Dylan E. Graetz
  • Asya Agulnik
  • Meenakshi Devidas
  • Ibrahim Qaddoumi

Best Publications

  • Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

    Jean-François Emile;Oussama Abla;Sylvie Fraitag;Annacarin Horne

  • Langerhans Cell Histiocytosis (LCH): Guidelines for Diagnosis, Clinical Work-Up, and Treatment for Patients Till the Age of 18 Years

    Riccardo Haupt;Milen Minkov;Itziar Astigarraga;Eva Schäfer

  • Inactivation of the p53 pathway in retinoblastoma

    Nikia A. Laurie;Stacy L. Donovan;Chie Schin Shih;Jiakun Zhang

  • Clinical and Outcome Characteristics of Children With Adrenocortical Tumors: A Report From the International Pediatric Adrenocortical Tumor Registry

    E. Michalkiewicz;R. Sandrini;B. Figueiredo;E.C.M. Miranda

  • The genomic landscape of pediatric Ewing sarcoma

    Brian D. Crompton;Chip Stewart;Amaro Taylor-Weiner;Gabriela Alexe

  • Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease

    Oussama Abla;Eric Jacobsen;Jennifer Picarsic;Zdenka Krenova

  • Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma

    Jennifer A. Perry;Adam Kiezun;Peter Tonzi;Eliezer M. Van Allen;Eliezer M. Van Allen

  • Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge

    Carlos Rodriguez-Galindo;Paola Friedrich;Patricia Alcasabas;Federico Antillon

  • Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma

    Daniel E. Bauer;Chelsey M. Mitchell;Kelly M. Strait;Christopher S. Lathan

  • The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017

    Lisa M. Force;Ibrahim Abdollahpour;Shailesh M Advani;Dominic Agius

  • Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO).

    Michael B. Jordan;Carl E. Allen;Jay Greenberg;Michael Henry

  • Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors

    E. Izumchenko;K. Paz;D. Ciznadija;I. Sloma

  • Childhood cancer burden: a review of global estimates.

    Nickhill Bhakta;Lisa M Force;Claudia Allemani;Rifat Atun

  • Soft tissue sarcoma across the age spectrum: A population-based study from the surveillance epidemiology and end results database†

    Andrea Ferrari;Iyad Sultan;Tseng Tien Huang;Carlos Rodriguez-Galindo

  • Sustainable care for children with cancer: a Lancet Oncology Commission

    Rifat Atun;Nickhill Bhakta;Avram Denburg;A Lindsay Frazier

  • A proposal for an international retinoblastoma staging system

    Guillermo Chantada;François Doz;Celia B.G. Antoneli;Richard Grundy

  • Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors

    Melinda S. Merchant;Matthew Wright;Kristin Baird;Leonard H. Wexler

  • Increase in the incidence of differentiated thyroid carcinoma in children, adolescents, and young adults: a population-based study.

    Lucas Bonachi Vergamini;A. Lindsay Frazier;Fernanda Laurinavicius Abrantes;Karina Braga Ribeiro

  • Treatment of Ewing sarcoma family of tumors: current status and outlook for the future.

    Carlos Rodriguez-Galindo;Carlos Rodriguez-Galindo;Sheri L Spunt;Alberto S Pappo

  • Abstract A41: Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma

    Adam Kiezun;Jennifer Perry;Peter Tonzi;Eliezer Van Allen

Frequent Co-Authors

Mark Krailo
Mark Krailo University of Southern California
Stephen P. Hunger
Stephen P. Hunger University of Pennsylvania
Raul C. Ribeiro
Raul C. Ribeiro St. Jude Children's Research Hospital
Charles W. M. Roberts
Charles W. M. Roberts St. Jude Children's Research Hospital
Gerard P. Zambetti
Gerard P. Zambetti St. Jude Children's Research Hospital
Wendy B. London
Wendy B. London Harvard University
Alberto S. Pappo
Alberto S. Pappo St. Jude Children's Research Hospital
Todd R. Golub
Todd R. Golub Harvard University
Gad Getz
Gad Getz Broad Institute
Scott L. Carter
Scott L. Carter Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degree options can open up diverse career pathways for those interested in Medicine and healthcare. Many professionals look for accelerated or flexible programs to advance their credentials efficiently while managing work and personal responsibilities.

For practicing nurses seeking leadership roles, choosing the shortest msn to dnp program can be a strategic way to earn a Doctor of Nursing Practice degree faster. Similarly, some may prefer dnp programs without dissertation to avoid extensive research requirements and focus more on clinical practice.

If you’re starting out in the nursing field, there are fast track lpn programs online designed to get you working and gaining experience in less time. For those interested in mental health, the fastest pmhnp program can help you become a specialized Psychiatric-Mental Health Nurse Practitioner through accelerated, flexible pathways.

These options make it possible to tailor your education to your career goals and available time, whether you are advancing in your current field or changing paths within healthcare.

Best Scientists Citing Carlos Rodriguez-Galindo

Trending Scientists

Recently Published Articles